Markets.com Logo

CMPS

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    4.0429$
  • Previous Close
    4.2989$
  • 52 Week Change
    6.29$
  • Day Range
    -0.26$
  • 52 Week High/Low
    2.25$ - 8.5367$
  • Dividend Per Share
    --
  • Market cap
    414 M$
  • EPS
    -0.4114
  • Beta
    2.175
  • Volume
    --

About

CMPS.US is the stock ticker symbol for Compass Pathways plc, a mental healthcare company focused on accelerating patient access to evidence-based innovation in mental health. Compass Pathways is developing COMP360 psilocybin therapy for treatment-resistant depression (TRD) and other mental health disorders. The company is listed on the Nasdaq Global Select Market under the ticker CMPS and operates primarily in the United States. As a publicly traded company, Compass Pathways' stock performance is subject to market fluctuations and investor sentiment regarding the biotechnology and mental health sectors, as well as the progress of its clinical trials and regulatory approvals for COMP360.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

Company Performance: Compass Pathways' clinical trial results, especially Phase 3 data for COMP360 in treatment-resistant depression, significantly impact investor confidence and stock price.

Regulatory Landscape: Changes in regulations surrounding psychedelic-assisted therapy, including potential FDA approval for COMP360, can drive substantial stock fluctuations.

Market Sentiment: General market conditions, investor risk appetite, and overall sentiment towards the pharmaceutical and biotechnology sectors influence CMPS's price.

Competition: Developments in the psychedelic medicine space, including progress by competitors in developing alternative therapies, affect investor perception of Compass Pathways' market position.

Partnerships & Funding: Collaborations with research institutions, pharmaceutical companies, or successful fundraising efforts can boost investor confidence and stock valuation.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--